Cynosure Expands Presence in China with the Opening of Sales Office in Beijing
June 25 2008 - 9:30AM
PR Newswire (US)
WESTFORD, Mass., June 25 /PRNewswire-FirstCall/ -- Cynosure, Inc.
(NASDAQ:CYNO), a leading developer and manufacturer of a broad
array of light-based aesthetic treatment systems, today announced
the opening of its second sales office in the People's Republic of
China. Located in the Chao Yang District of Beijing, the office
will be headed by Aileen Ren, vice general manager of sales and
marketing for Cynosure China, the company's wholly owned
subsidiary. Cynosure also has a sales office in Suzhou, located
approximately an hour northwest of Shanghai. "Consistent with our
strategy, we are continuing to broaden the global reach of our
newest aesthetic laser systems in key international markets," said
President and Chief Executive Officer Michael Davin. "China, with
its rapidly growing affluent middle class and the world's largest
population, is an important region for Cynosure. We have operated
in the People's Republic since 1995 and in 2006 we became the first
U.S. aesthetic laser company to establish a wholly owned subsidiary
there. Following on the successful introduction of our Elite(TM)
family of workstations in China last year, we are continuing to
pursue additional regulatory approvals of our flagship products for
this expanding market." About Cynosure, Inc. Cynosure, Inc.
develops and markets aesthetic treatment systems that are used by
physicians and other practitioners to perform non-invasive and
minimally invasive procedures to remove hair, treat vascular
lesions, rejuvenate skin through the treatment of shallow vascular
and pigmented lesions, laser lipolysis and temporarily reduce the
appearance of cellulite. Cynosure's products include a broad range
of laser and other light-based energy sources, including
Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as
intense pulsed light. Cynosure was founded in 1991. For corporate
or product information, contact Cynosure at 800-886-2966, or visit
http://www.cynosure.com/. Safe Harbor This press release about
future expectations, plans and prospects for Cynosure in the
People's Republic of China includes forward-looking statements
within the meaning of The Private Securities Litigation Reform Act
of 1995. These statements contain the words "believes,"
"anticipates," plans," "expects," "will" and similar expressions.
Actual results may differ materially from those indicated by such
forward-looking statements as a result of various important
factors, including Cynosure's history of operating losses, its
reliance on sole source suppliers, the inability to accurately
predict Cynosure's success in China, changes in consumer
preferences, competition in the aesthetic laser industry, as well
as economic, market, technological and other factors discussed in
Cynosure's most recent Annual Report on Form 10-K, which is filed
with the Securities and Exchange Commission. In addition, the
forward-looking statements included in this press release represent
Cynosure's views as of the date of this press release. Cynosure
anticipates that subsequent events and developments will cause its
views to change. However, while Cynosure may elect to update these
forward- looking statements at some point in the future, it
specifically disclaims any obligation to do so. These
forward-looking statements should not be relied upon as
representing Cynosure's views as of any date subsequent to the date
of this press release. Contact: Scott Solomon Vice President Sharon
Merrill Associates, Inc. 617.542.5300 DATASOURCE: Cynosure, Inc.
CONTACT: Scott Solomon, Vice President of Sharon Merrill
Associates, Inc., +1-617-542-5300, , for Cynosure, Inc. Web site:
http://www.cynosure.com/
Copyright
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From May 2024 to Jun 2024
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jun 2023 to Jun 2024